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Abstract
CD80 plays a critical role in stimulation of T cells and subsequent control of infection. To investigate the effect of CD80 on
HSV-1 infection, we constructed a recombinant HSV-1 virus that expresses two copies of the CD80 gene in place of the
latency associated transcript (LAT). This mutant virus (HSV-CD80) expressed high levels of CD80 and had similar virus
replication kinetics as control viruses in rabbit skin cells. In contrast to parental virus, this CD80 expressing recombinant
virus replicated efficiently in immature dendritic cells (DCs). Additionally, the susceptibility of immature DCs to HSV-CD80
infection was mediated by CD80 binding to PD-L1 on DCs. This interaction also contributed to a significant increase in T cell
activation. Taken together, these results suggest that inclusion of CD80 as a vaccine adjuvant may promote increased
vaccine efficacy by enhancing the immune response directly and also indirectly by targeting to DC.
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Introduction
Dendritic cells (DCs) are bone marrow-derived cells that are
involved in antigen capture, processing, and presentation and are
the most powerful of the antigen presenting cells (APCs), playing a
key role in triggering the immune system against infectious agents
[1–6]. DCs perform crucial roles in linking innate and adaptive
immunity and thus play a key role in triggering the immune system
against HSV-1 infection [7–9].
Recently, we showed that although DCs can be infected by
HSV-1, DCs do not support HSV-1 replication and are
impervious to cell lysis [10]. However, the mechanism of DCs
resistance to HSV-1 replication is not known. In addition, we have
reported that in contrast to bone marrow (BM)-derived DCs from
wild type mice, DCs isolated from signal transducers and
activators of transcription-1 deficient (STAT1
-/-) mice were
susceptible to HSV-1 replication [10]. Binding of CD28 on T
cells to CD80 (B7-1) or CD86 (B7-2) on an APC leads to T cell
proliferation, differentiation, and cytokine secretion [11]. The
CD80 and CD86 molecules are expressed by multiple cell types,
including B cells, macrophages, DCs, and T cells [12–15].
In addition to CD80 and CD86, the B7 pathways comprise the
Programmed Death-1 (PD-1) receptor (CD279) and its two
ligands, PD-L1 (B7-H1; CD274) and PD-L2 (B7-DC; CD273)
[16,17]. PD-L1 and PD-L2 expression patterns are different; PD-
L1 is constitutively expressed on many cell types such as T cells, B
cells, macrophages, DCs, and BM-derived mast cells, while PD-L2
expression is more restricted [18]. Recently we have shown that
CD80 binds to PD-L1 and this interaction inhibited T cell
proliferation and cytokine production [19].
It was previously shown that DCs were not productively
infected despite the fact that DCs express HSV receptors [20].
However, in our hands, few BM-derived DCs expressed HVEM
or nectin-1, the two most prominent HSV-1 receptors. The studies
presented here utilize a recombinant HSV-1 virus constructed
such that it expresses the CD80 gene (HSV-CD80) in an attempt
to determine if CD80 expressed by this recombinant virus would
bind to PD-L1 expressed on DCs and lead to productive infection
and lysis of cells. Our results suggested that viral CD80 binds to
PD-L1 on the surface of DCs and facilitates cell infection and lysis.
Furthermore, this binding reduced T cell exhaustion in vitro
independent of CD28. This study lays the framework for a strategy
that could be used to prevent and/or significantly reduce T cell
exhaustion and thus increase vaccine efficacy against both virus
replication in the eye and latency in the TG.
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Structure of the HSV-CD80 recombinant virus
Previously we constructed several HSV-1 recombinant viruses
expressing various genes using the LAT promoter [21,22]. In these
studies, by using the LAT promoter, we have shown high
expression of each gene during both primary and latent infections.
This strategy overcame the problems inherent in the temporary
expression of various genes provided by immediate early (IE) or
HCMV IE promoter. Thus, in this study we constructed a
recombinant derivative of HSV-1 strain McKrae that expresses
two complete copies of the murine CD80 gene to examine the
effects of CD80 expression on HSV-1 infectivity. The genomic
structure of the wt HSV-1 strain McKrae is shown schematically
in figure 1A. The HSV-1 genome contains a unique long region
(UL) and a unique short region (US) both of which are flanked by
inverted repeats {designated by the open rectangles; terminal and
internal repeats long (TRL and IRL) and terminal and internal
repeats short (TRS and IRS)}. The previously described LAT null
mutant, dLAT2903 (Fig. 1B), was derived from the HSV-1
McKrae strain [23]. It contains a 1.8 kb deletion in both copies of
the LAT gene (one in each of the long repeats). This deletion
encompasses 0.2 kb of the LAT promoter and the portion of the
LAT gene that encodes the first 1.6 kb of the 8.3 kb primary LAT
transcript. The deleted region, designated as ‘‘XXXXXX’’
(Fig. 1B), extends to LAT nt position +1667.
HSV-CD80 was derived from dLAT2903 by insertion of the
CD80 gene ORF and restoration of the LAT promoter (Fig. 1C,
described in Materials and Methods). The genomic structure of
HSV-CD80 was confirmed by restriction enzyme analysis,
Southern blot, and partial sequencing (not shown). HSV-CD80
contains the entire sequence of the CD80 gene, including its
polyadenylation signal, under the control of the LAT promoter.
There is a non-coding region of 47 nt upstream of the first ATG.
This is followed by the complete coding region of 948 nt and a
100 nt non-coding region downstream of the CD80 termination
codon that contains the CD80 gene polyA signal. Thus, HSV-
CD80 and dLAT2903 are both LAT null mutants and HSV-
CD80 is identical to dLAT2903 except that the LAT promoter has
been restored and it drives expression of the inserted CD80 gene
followed by a polyA signal. In the studies below, HSV-CD80 is
compared to its parental virus, dLAT2903.
Replication of HSV-CD80 in RS cells
RS cells were infected with 1 PFU/cell of HSV-CD80 or
parental virus. The monolayers were freeze-thawed at the
indicated times, and virus yield was determined as described in
Materials and Methods. Replication of HSV-CD80 appeared
similar to that of parental virus (Fig. 2; P.0.05 at all-time points).
This suggests that the recombinantly expressed CD80 had no
direct effect on virus replication in tissue culture. It also strongly
suggests that the recombinant HSV-CD80 does not contain any
unexpected mutations that effect virus replication in tissue culture.
HSV-CD80 replication in DCs
We and others have shown that BM-derived DCs isolated from
mice [10] and from blood of humans are refractory to HSV-1
infection [24–26]. We tested whether murine BM-derived DCs
were similarly resistant to HSV-CD80 infection. DCs isolated
from C57BL/6 mice were cultured in the presence of GM-CSF as
described in Materials and Methods and then infected with 1 or
10 PFU/cell of HSV-CD80 or parental virus. The kinetics of virus
replication were quantitated by determining the amount of
infectious virus at various times PI using a plaque assay as
described in Materials and Methods. Replication of HSV-CD80 in
DCs infected with 1 (Fig. 3A) or 10 (Fig. 3B) PFU was significantly
higher than that seen in parental virus infected cells at all-time
points. Similar results were obtained when DCs from SVE129
(Fig. 3C) and BALB/c (Fig. 3D) mice were infected with HSV-
CD80. Thus, HSV-CD80 infects and replicates with high
efficiency in BM-derived DCs isolated from three different strains
of mice and the drop of viral titers at later times post infection is
most likely related to DC killing by the virus.
Higher HSV-1 gene expression in HSV-CD80 infected DCs
To confirm that the above viral replication results are reflected
in HSV-1 gene expression, we used ICP0 as an indicator of
Figure 1. Construction and structure of the HSV-CD80 recombinant virus. (A) The top schematic diagram shows the HSV-1 McKrae genome
in the prototypic orientation. TRL and IRL represent the terminal and internal (or inverted) long repeats, respectively, and TRS and IRS represent the
terminal and internal (or inverted) short repeats, respectively. UL and US represent the long and short unique regions, respectively. The solid rectangle
represents the very stable 2 kb LAT. (B) dLAT2903 (parental virus for HSV-CD80) has a deletion from LAT nucleotides 2161 to +1667 in both copies of
LAT and makes no LAT RNA. (C) HSV-CD80 was constructed from dLAT2903 by homologous recombination between dLAT2903 DNA and a plasmid
containing the complete LAT promoter and the entire structural CD80 gene (including its 39 poly(A) signal) as described in Materials and Methods.
doi:10.1371/journal.pone.0087617.g001
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early (E) gene expression. We infected DCs with 1 PFU/cell of
HSV-CD80 or parental virus and harvested cells at 4, 8, 12 hr PI.
TaqMan RT-PCR of isolated total RNA was used to compare
ICP0 and TK mRNA levels to baseline levels (just prior to
infection). Cellular GAPDH mRNA was used as an internal
control. Between 4 hr and 12 hr PI, ICP0 (Fig. 4A, ICP0) and TK
(Fig. 4B, TK) transcripts were significantly higher in HSV-CD80
infected DCs than in parental virus infected DCs (p,0.0001 at all
three time points). These results were consistent with increased
viral replication in HSV-CD80 infected DCs compared to
parental virus infected DCs (Fig. 3). The drop in ICP-0 expression
at later times post infection in HSV-CD80 infected DCs is
probably associated with DCs killing by the virus.
To confirm expression of CD80 by HSV-CD80, the expression
of CD80 mRNA was determined. DCs were infected with HSV-
CD80 or parental virus at a multiplicity of 1 PFU/cell. Infected
cells were collected 2, 4, 8, 12, 24, and 48 hr PI. TaqMan RT-
PCR was performed on isolated total RNA to detect CD80
transcripts. As expected, the level of CD80 RNA in HSV-CD80-
infected DCs was significantly higher than in parental-infected
DCs at 2, 4 and 8 hr PI (Fig. 4C; p,0.001), indicating that the
presence of two copies of CD80 in HSV-CD80 leads to increased
expression of CD80 during the early period of infection. The
reason for the decline in CD80 transcript at 12, 24, and 48 hr PI is
not presently understood, but may be due to decreased LAT
promoter activity and/or cell lysis of infected cells.
Since increased mRNA levels suggest increased protein
expression, increased virus protein expression was confirmed by
FACS analyses. DCs were infected as above with 1 PFU/cell. At
24 hr PI, the number of HSV-1 infected DCs expressing CD80
was determined using flow cytometry. Approximately 29.7% of
DCs infected with HSV-CD80 co-expressed CD11c and HSV-gC
compared with 6.8% and 5.3% in parental and mock infected
DCs, respectively (Fig. 5A). In addition, 31% of cells were
CD11C-negative but gC-positive in the HSV-CD80 group
compared with 3.1% and 1.9% in parental and mock infected
DCs, respectively (Fig. 5A). In addition, 15% of DCs infected with
HSV-CD80 were positive for expression of both CD80 and HSV-
1-gC compared with only 1% for the parental or mock groups
(Fig 5B).
The RT-PCR and FACS analyses were additionally confirmed
by immunostaining. Briefly, DCs were grown on Lab-Tex
chamber slides and infected with 1 or 10 PFU/cell of HSV-
CD80 or parental virus for 12 or 24 hr. At both 12 and 24 hr PI,
gC expression in HSV-CD80 infected DCs was higher with
10 PFU versus 1 PFU (Fig. 5C). In contrast, no gC-positive cells
were detected in DCs that were infected with 1 or 10 PFU/cell of
parental virus (Fig. 5C). Similarly no gC positive cells were
detected in DCs that were infected with 1 PFU of parental virus
for 24 hr, while some positive cells were detected at 10 PFU/cell
(Fig. 5C, parental, 10 PFU). Quantitative image analyses of HSV-
1 gC stained slides described in figure 5C revealed significant
increases in HSV-CD80 versus parental virus for both time points
and infectious doses (Fig. 5D, p,0.001). Thus, these results
provide confirmatory evidence that HSV-CD80 infects DCs more
efficiently than parental virus. We also looked at the maturation
state of DCs (Figure S1). DCs were prepared as above and stained
with anti-CD11c, anti-CD69 and anti-CD83 antibodies. As
expected significant numbers of DCs appeared to be immature
DCs (Figure S1).
Colocalization of HSV-CD80 expressed CD80 to PD-L1 is
required for HSV-1 infectivity
Previously we have shown that CD80 binds to PD-L1 [19]. To
confirm that HSV-CD80 expressed CD80 binds to PD-L1 on
DCs, DCs were infected with HSV-CD80, parental virus, or
mock-infected as described above. At 24 h PI, the infected DCs
were isolated and three-color FACS analyses performed using
anti-CD11c, anti-PD-L1, and anti-HSV-1 gC antibodies. DCs
were gated on CD11c+ cells and analyzed for expression of PD-L1
and HSV-1 gC (Fig. 6A). The level of co-expression of HSV-1 gC
and PD-L1 in HSV-CD80 infected CD11c
+ cells was higher (12%)
than in parental virus infected cells (0.6%) or mock (0.1%)
(Fig. 6A).
To determine if the presence of PD-L1 is required for
colocalization and thus infectivity of DCs by HSV-CD80, DCs
from WT, PD-L1
-/-, and PD-L2
-/- mice were infected with HSV-
CD80, parental virus, or mock-infected and analyzed by FACS
24 hr PI as described above. As expected, HSV-CD80 infected
DCs from PD-L1
-/- mice had few PD-L1
+/CD80
+ DCs but both
WT and PD-L2
-/- had substantial numbers of PD-L1
+/CD80
+
DCs (Fig. 6B, HSV-CD80). In DCs infected with parental virus or
mock, the number of PD-L1
+/CD80
+ DCs was low from WT,
PD-L1
-/-, and PD-L2
-/- mice (Fig. 6B).
DCs from WT, PD-L1
-/-, and PD-L2
-/- mice were grown on
Lab-Tex chamber slides and infected with 1 PFU of HSV-CD80
or parental virus for 24 hr. Infected DCs were stained with anti-
HSV-1 gC, anti-CD80, and anti-PD-L1 antibodies. Only WT and
PD-L2
-/- DCs infected with HSV-CD80 were positive for HSV-1
gC whereas PD-L1
-/- DCs infected with HSV-CD80 were not
(Fig. 6C). Consistent with the above results, DCs from WT, PD-
L1
-/-, and PD-L2
-/- mice infected with parental virus were
negative for expression of HSV-1 gC (Fig. 6C, HSV-1 gC (FITC)).
However, DCs from all groups were positive for expression of
CD80 (Fig. 6C, CD80 (TRITC)), while DCs from WT and PD-
L2
-/- mice (but not from PD-L1
-/-mice) were positive for
expression of PD-L1 (Fig. 6C, PD-L1 (APC)). Merging HSV-1
Figure 2. Replication of HSV-CD80 recombinant virus in RS
cells. Subconfluent RS cell monolayers in triplicate from two separate
experiments were infected with 1 PFU/cell of HSV-CD80 or parental
dLAT2903 virus as described in Materials and Methods. Total virus was
harvested at the indicated times PI by two cycles of freeze-thawing. The
amount of virus at each time point was determined by standard plaque
assays on RS cells. Each point represents the mean + SEM (n=6).
doi:10.1371/journal.pone.0087617.g002
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PLOS ONE | www.plosone.org 3 January 2014 | Volume 9 | Issue 1 | e87617Figure 3. Replication of HSV-CD80 recombinant virus in BM-derived DCs. Subconfluent monolayers of DCs isolated from C57BL/6, 129SVE,
and BALB/c mice were infected with 10 PFU/cell of HSV-CD80 or parental virus as described in Materials and Methods. In some experiments DCs from
C57BL/6 mice were infected with 1 PFU/cell of each virus, while DCs from 129SVE were infected with 10 PFU/cell of wt HSV-1 strain McKrae. Virus
yield was determined at the indicated times PI by standard plaque assays. Panels: A) DCs from C57BL/6 mice were infected at 1 PFU/cell of HSV-CD80
or parental virus; B) DCs from C57BL/6 mice were infected at 10 PFU/cell of HSV-CD80 or parental virus; C) DCs from 129SVE mice were infected at
10 PFU/cell of HSV-CD80, parental, and wt McKrae viruses; and D) DCs from BALB/c mice were infected at 10 PFU/cell of HSV-CD80 or parental virus.
Each point represents the mean 6 SEM (n=6) from two separate experiments.
doi:10.1371/journal.pone.0087617.g003
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L2
-/- and not PD-L1
-/- mice infected with HSV-CD80 were
gC
+CD80
+PD-L1
+ (Fig. 6C, Merge).
To confirm the above results (Fig. 6A–C) that the presence of
PD-L1 is required for infection of DCs by HSV-CD80, DCs from
WT, PD-L1
-/-, and PD-L2
-/- mice were isolated and infected with
1 PFU/cell of HSV-CD80 or parental virus. The kinetics of virus
replication were quantitated by determining the amount of
infectious virus at 0, 12, 24, and 48 PI using a plaque assay as
described in Materials and Methods. Replication of WT and PD-
L2
-/- DCs infected with HSV-CD80 was significantly higher than
that seen in PD-L1
-/- or parental virus infected cells at all-time
points (Fig. 6D; p,0.0001). Thus, the presence of PD-L1 is
required for DCs to be efficiently infected with HSV-CD80.
In figure 6D we have shown that DCs from PD-L1
-/- mice but
not from WT or PD-L2
-/- mice are refractory to infection by
HSV-CD80 recombinant virus. The lack of effective infection in
DCs from PD-L1
-/- mice could be due to the absence of some
other factors for virus entry, thus to rule out these possibilities,
DCs from WT mice were incubated with anti-PD-L1 mAb,
10F.2H11, or irrelevant antibody. This mAb specifically blocks
interaction of PD-L1 with CD80 but not with PD-1 [19]. Virus
replications were quantitated at 0, 12, 24, and 48 PI using a
standard plaque assay. Replication of DCs incubated with
irrelevant antibody was the same as control with no antibody
and both were significantly higher than that seen in DCs
incubated with 10F.2H11 mAb at all-time points (Fig. 6E;
p,0.0001). Thus, colocalization of CD80 to PD-L1 is required
for DCs to be efficiently infected with HSV-CD80.
Reduction of T cell exhaustion in the presence of DCs
infected with HSV-CD80
Previously we showed that DC depletion reduces the establish-
ment of latent infection in the TG of ocularly infected mice [8,9],
and this reduction in the level of latency correlates with lower
expression of PD-1 [27,28]. To investigate the potential effect of
DCs on T cell exhaustion, we infected BM-derived DCs from wt
mice with HSV-CD80, parental virus or mock infected as
described above. At 24 hr post incubation, the level of PD-1
expression on T cells was only 3% in HSV-CD80 infected DCs
compared with 56% in mock-infected DCs and 83% in parental
virus infected DCs (Fig. 7). Approximately 30% of T cells
incubated alone (Fig. 7, no DCs) or infected with each virus were
positive for expression of PD-1 (not shown). At 48 hr PI the level of
T cells expressing PD-1 was 91% in the mock-infected group, 87%
in the parental virus infected group, and 46% in the HSV-CD80
virus infected group (not shown). These results suggest that in this
assay DCs contributed to an increase of PD-1 expression on T cells
and PD-1 expression was reduced by CD80 expression in HSV-
CD80 infected DCs.
To determine the possible role of CD28 in the increase of PD-1
expression, DCs isolated from WT mice described above were
incubated with T cells isolated from CD28
-/- mice at a 1:1 ratio.
The level of PD-1 expression did not change in HSV-CD80
infected DCs in the presence or absence of CD28 (Figure S2).
Thus, our results suggest that in the presence of exogenous
expression of CD80, CD28 did not alter expression of PD-1 on T
cells.
Increase IFN-c expression in the presence of DCs infected
with HSV-CD80
The above results suggest that in the presence of exogenous
expression of CD80, PD-1 expression on T cells significantly
Figure 4. Level of HSV-1 immediate early, early, and CD80 in
HSV-CD80 infected DCs. Subconfluent monolayers of DCs from
C57BL/6 mice were infected with 1 PFU/cell of HSV-CD80 or parental
virus as in Fig. 1. For ICP-0 and TK measurements, cells were isolated 4,
8, and 12 hr PI, while for CD80 measurements cells were harvested 2, 4,
8, 12, 24, and 48 hr PI. Total RNA was isolated and TaqMan RT-PCR was
performed using ICP0-, TK-, and CD80-specific primers as described in
Materials and Methods. ICP0 and TK mRNA levels were normalized in
comparison to each transcript at 0 hr PI, while CD80 mRNA level was
normalized to the level of CD80 in mock infected DCs. GAPDH was used
as internal control. Each point represents the mean 6 SEM (n=6) from
two separate experiments. Panels: A) ICP-0; B) TK, and C) CD80.
doi:10.1371/journal.pone.0087617.g004
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PLOS ONE | www.plosone.org 6 January 2014 | Volume 9 | Issue 1 | e87617Figure 6. Colocalization of PD-L1 on DCs to CD80 expressed by HSV-CD80 and its effect on virus replication. A) FACS analyses of
infected WT DCs. Subconfluent monolayers of DCs isolated from WT C57BL/6 mice were infected with 1 PFU/cell of HSV-CD80, parental virus, or mock
infected. At 24 hr PI, cells were harvested and reacted with anti-CD11c, anti-HSV-1 gC, and anti-PD-L1 antibodies and three-color FACS analysis was
performed. CD11c
+ gated cells were analyzed for expression of HSV-1 gC and PD-L1. Experiments were repeated twice; B) FACS analyses of DCs from
knockout mice. DCs from C57BL/6 WT, C57BL/6-PD-L1
-/- and C57BL/6-PD-L-2
-/- mice were infected with 1 PFU/cell of HSV-CD80, parental virus, or
mock infected. At 24 hr PI, cells were harvested and reacted with anti-CD11c, anti-CD80, and anti-PD-L1 antibodies and three-color FACS analysis was
performed. CD11c
+ gated cells were analyzed for expression of CD80 and PD-L1. Experiments were repeated twice; C) Immunostaining of DCs from
knockout mice. DCs from WT BALB/c, BALB/c-PD-L1
-/- and BALB/c-PD-L-2
-/- mice were infected with 1 PFU/cell of HSV-CD80 or parental virus. At 24 hr
PI, cells were reacted with anti-HSV-1 gC, anti-CD80, and anti-PD-L1 antibodies. DAPI is shown as a nuclear counter-stain; D) Replication of HSV-CD80
in DCs isolated from knockout mice. Subconfluent monolayers of DCs isolated from WT BALB/c, BALB/c-PD-L1
-/- and BALB/c-PD-L-2
-/- mice were
infected with 1 PFU/cell of HSV- CD80 or parental virus as described in Materials and Methods. Virus yield was determined at the indicated times by
standard plaque assays. Each point represents the mean 6 SEM (n=6) from two separate experiments; and E) Replication of HSV-CD80 in WT C57BL/
6 DCs in presence of blocking antibody. Subconfluent monolayers of DCs were incubated with 10F.2H11 antibody, irrelevant antibody, or no
antibody and infected with 1 PFU/cell of HSV-CD80 as described in Materials and Methods. Virus yield was determined at the indicated times by
standard plaque assays. Each point represents the mean 6 SEM (n=6).
doi:10.1371/journal.pone.0087617.g006
Figure 5. Expression of CD80 by HSV-CD80 in infected DCs. A) Detection of HSV-1 gC in infected DCs. Subconfluent monolayers of DCs
isolated from C57BL/6 mice were infected with 1 PFU/cell of HSV-CD80, parental virus, or mock infected. At 24 hr PI, cells were harvested and reacted
with anti-CD11c and anti-HSV-1 gC antibodies and FACS analysis was performed (see Materials and Methods). Experiments were repeated twice; B)
FACS analyses of infected DCs for expression of HSV-1 gC and CD80. Monolayers of DCs were treated as above. At 24 hr PI, cells were harvested and
reacted with anti-CD11c, anti-HSV-1 gC, and anti-CD80 antibodies and FACS analysis was performed. CD11c
+ cells were gated for expression of HSV-1
gC and CD80. Experiments were repeated twice; C) Immunostaining of HSV-CD80 infected DCs. DCs were infected with 1 or 10 PFU/cell of HSV-CD80
or parental virus. At 12 and 24 hr PI, cells were stained with anti-HSV-1 gC antibody and subjected to IHC as descried in Materials and Methods; and
D) Quantification of photomicrographs from C. Different areas of 3 slides/virus/pfu/time point from IHC described above were imaged and the
number of HSV-1 gC
+ cells was counted. Each point represents the mean 6 SEM of HSV-1 gC
+ DCs from 12 images.
doi:10.1371/journal.pone.0087617.g005
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activation of T cells, T cells were co-cultured for 24 and 48 hr with
DCs as above and the relative level of IFN-c was determined by
RT-PCR of total T cells isolated from the co-culture. The results
are presented as ‘‘fold’’ increase (or decrease) compared to the
baseline mRNA levels in T cells that were not co-cultured with
DCs (Fig. 8). At 24 hr post co-culture, the level of IFN-c
expression in T cells incubated with mock uninfected DCs was
significantly lower than the levels of IFN-c expression in T cells
incubated with parental or HSV-CD80 infected DCs (Fig. 8; 24 hr
post co-culture; p,0.0001). Similarly, the level of IFN-c expres-
sion in T cells incubated with uninfected DCs at 48 hr post co-
culture was lower than the levels of IFN-c expression in T cells
incubated with parental or HSV-CD80 infected DCs (Fig. 8; 48 hr
post co-culture). At both 24 and 48 hr post co-culture the level of
IFN-c expression was significantly higher in the HSV-CD80 group
compared to the parental group or mock group (P,0.0001).
However, by 48 hr post co-culture the level of IFN-c expression in
both parental-infected and HSV-CD80-infected groups but not
mock-infected group declined due to higher cell death using
trypan blue. Overall, our results suggest that the blocking of PD-
L1 by CD80 enhances IFN-c production by T cells.
Discussion
Herpes simplex virus (HSV) infections are among the most
frequent serious viral infections in the U.S. and are considered to
be a major health issue in developed countries [29–33]. DCs
Figure 7. Coculture of HSV-CD80 infected DCs with naive WT T cells reduces CD3
+PD-1
+ expression. DCs from WT C57BL/6 mice were
infected with 1 PFU/cell of HSV-CD80, parental virus, or mock-infected. At 24 hr PI, the infected DCs were incubated with T cells isolated from naive
WT C57BL/6 mice at a 1:1 ratio. As a control some T cells were incubated without DCs. FACS analyses were carried out 24 post incubation using anti-
CD3 and anti-PD-1 antibodies. Graphs show the contour of CD3
+PD-1
+ staining for each group. Panels represent HSV-CD80, Parental virus, Mock, and
no DCs T cells. Number indicates the percent of PD-1
+CD3
+ expressing T cells per treatment. Experiments were repeated twice.
doi:10.1371/journal.pone.0087617.g007
Figure 8. Co-culture of HSV-CD80 infected DCs with naive WT T cells increases IFN-c expression. DCs from WT C57BL/6 mice were
infected with 1 PFU/cell of HSV-CD80, parental virus, or mock-infected as in figure 7. At 24 and 48 hr PI, the infected DCs were incubated with T cells
isolated from naive WT C57BL/6 mice at a 1:1 ratio. As a control some T cells were incubated without DCs. At 24 and 48 hr PI, T cells were isolated and
quantitative RT-PCR for IFN-c expression was performed using total RNA. IFN-c expression in control T cells that were not incubated with DCs was
used to estimate the relative expression of IFN-c transcript in T cells that were co-cultured with mock-infected or infected DCs. GAPDH expression
was used to normalize the relative expression of IFN-c transcript in co-cultured T cells. Each point represents the mean 6 SEM from 3 experiments.
doi:10.1371/journal.pone.0087617.g008
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augmenting the immune response to HSV-1 infection [34].
Previously it was reported that freshly isolated peripheral blood
monocytes and lymphocytes are refractory to HSV infection [24–
26,35]. Similarly, previously we showed that BM-derived DCs
could be moderately infected with HSV-1, but the virus does not
replicate efficiently [10]. In contrast, other studies showed that
while both mature and immature monocyte-derived DCs are
infected by HSV-1, only immature DCs produce infectious virus,
but at ten-fold lower levels than most cell lines [20,36]. In this
study we showed that BM-derived CD11c
+ DCs express low levels
of CD83/CD69 (Figure S1). During the activation/maturation
state, DCs express both CD83 and CD69 that are not detected
under resting conditions [37–40]. Thus, in this study we have
shown that BM-derived DCs are immature and are susceptible to
HSV-CD80 infection but not WT HSV-1.
We also report here that HSV-CD80 infects DCs as efficiently
as highly permissive RS cells. This attachment and subsequent
infection involves colocalization of CD80 to PD-L1 on DCs. This
suggests that the non-permissiveness of immature DCs for HSV-1
may be due to low expression of HSV-1 receptors rather than
inefficient virus penetration or a block in virus replication. In this
study we detected expression of both nectin-1 (Figure S3A) and
herpesvirus entry mediator (HVEM) (Figure S3B) on DCs, but less
than 10% of the total DC population expressed these two
receptors (Figure S3C). Previously it was reported that both
immature and mature monocyte-derived DCs (MDDCs) in
humans express the HSV receptors nectin-1 and HVEM as
determined by FACS using single staining for each receptor [41].
This discrepancy between our results and previous results may be
due to the differences in the source of DCs that we used and/or
because we looked at expression of these receptors in CD11c
+
cells.
Because of the critical role that DCs play in linking innate and
adaptive immune responses, there is increasing interest in using
signals that are known to activate DCs to stimulate and improve
vaccine efficacy. However, due to their possible immunothera-
peutic potential, the negative aspects of DCs have received far less
attention than their role as ‘‘immune saviors’’. Vaccinia virus
abortively infects both mature and immature DCs and blocks their
maturation; hence, T cell activation is impaired [42]. By inhibiting
the maturation pathway of DCs and inducing their death,
Vaccinia virus can subvert the development of efficient antiviral
T cell immunity. Similarly, we have shown that DCs contribute to
T cell exhaustion [43]. In this study we showed that T cells
incubated with DCs infected with HSV-CD80 had less T cell
exhaustion (as measured by PD-1 expression) and higher
expression of IFN-c than T cells incubated with mock-infected
or parental-infected DCs. The reduced PD-1 could be due to
competition between PD-1 and CD80 for binding to PD-L1.
However, binding of HSV-expressed CD80 to CD28 did not have
any effect on the expression level of CD3
+PD-1
+. Nevertheless, the
absence of CD28 had a positive effect on the level of T cell
exhaustion in mock infected or parental virus infected DCs. In
addition, our results confirm recent findings that blocking PD-L1
enhances IFN-c production by T cells [44].
The roles that PD-L1 plays in T cell activation are controversial.
Some studies have demonstrated inhibitory functions for PD-L1
[45], while others have reported that PD-L1 can stimulate T cell
proliferation and cytokine production [46]. The functional
significance of PD-1 and PD-L1 but not PD-L2 in HSV-1 latency
was demonstrated by the significantly reduced amount of HSV-1
latency in PD-1 and PD-L1 deficient mice and by the observation
that T cell exhaustion during latent HSV-1 infection correlates
with higher levels of latency and reactivation in mice [28]. Thus,
HSV-1 may use T cell exhaustion as a means of self-survival.
Although T cells maintain an exhausted phenotype after antigen
withdrawal and population reexpansion [47], T cell exhaustion
can be reversed by anti-PD-L1 antibody [48-51]. In this context
the potential for autoimmunity induction by DCs, particularly in
response to persistent viral infection has been suggested [52]. In
our published studies we have shown that depletion of DCs
significantly reduced the amount of latency in TG of infected
mice, while it had no effect on eye disease, survival, or virus
replication in eyes of ocularly infected mice [8,9]. Consequently,
controlling this negative function of DCs by inclusion of CD80 to
compete with PD-L1 for its binding to PD-1 might offer potential
prophylactic as well as therapeutic targets for the modulation of
immune responses in HSV-1-induced latency and reactivation.
Also direct binding of CD80 expressed by HSV-CD80 to CD28
on T cells with regards to T cell proliferation and cytokine
production cannot be ruled out despite the fact that the level of T
cell exhaustion was not altered in presence or absence of CD28.
Similar to this study, previously it was shown that PD-1/PD-L1
blockade restored function to T cells [48–50,53–55] and this
blockade has been shown to have clinical potentials [56,57]. In
conclusion, this study offers a novel strategy for how CD80 can be
used to alter T cell exhaustion and restore a functional T cell
population.
Materials and Methods
Ethics Statement
All animal procedures were performed in strict accordance with
the Association for Research in Vision and Ophthalmology
Statement for the Use of Animals in Ophthalmic and Vision
Research and the NIH Guide for the Care and Use of Laboratory Animals
(ISBN 0-309-05377-3). Animal research protocol was approved by
the Institutional Animal Care and Use Committee of Cedars-Sinai
Medical Center (Protocols #2490 and 2309).
Viruses, cells, and mice
Triple plaque purified wt McKrae (WT), dLAT2903 (LAT-
null), and HSV-CD80 (LAT-null) viruses were used in this study.
Since dLAT2903 (LAT-null) is the parental virus for HSV-CD80,
throughout the study, dLAT2903 virus is called parental virus.
Rabbit skin (RS) cells (used for the preparation of virus stocks, the
culturing of mouse tear films, and the determination of growth
kinetics) were grown in Eagle’s minimal essential media (MEM)
supplemented with 5% FCS. Six week old wild-type (wt) C57BL/
6, C57BL/6-CD28
-/-, and BALB/c mice were purchased from
Jackson Laboratory (Bar Harbor, Maine), while 129SVE mice
were purchased from Taconic Farm. C57BL/6-PD-L1
-/-,
C57BL/6-PD-L2
-/-, BALB/c-PD-L1
-/-, and BALB/c-PD-L2
-/-
mice have been reported previously [58,59] and were bred in-
house. Mice were used as a source of bone marrow (BM) for the
generation of cultured murine DCs.
Construction of the CD80 plasmid
Construction of pLAT that was used to insert the CD80 gene
was described previously [23]. A plasmid containing the murine
CD80 (B7-1) gene was digested with XbaI/HincII (ATCC clone
63369). This insert contained the complete 316 amino acid coding
region of the CD80 gene plus 47 and 100 bp of non-coding
sequence in its 59 and 39 region, respectively. After the addition of
a BgLII linker, the insert was ligated into the BamHI site of pLAT
and the resulting plasmid was designated pLAT-CD80. This
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2989 bp LAT fragments.
Construction of HSV-CD80 recombinant virus
HSV-CD80 recombinant virus was generated by homologous
recombination as we previously described [22,60,61]. Briefly,
pLAT-CD80 was co-transfected with infectious dLAT2903 DNA
using the calcium phosphate method. Viruses from the co-
transfection were plated, and isolated plaques were picked and
screened for the CD80 gene insertion using restriction digestion
and Southern blot analysis. Selected plaques that contained the
CD80 gene were plaque purified eight times and reanalyzed by
restriction digestion and Southern blot analysis to verify that the
CD80 gene was present in the LAT region. A single plaque was
chosen for purification and was designated HSV-CD80. This virus
contains the CD80 gene in the normal LAT location in the viral
genome and is under control of the LAT promoter. Thus, this
virus contains two copies of the CD80 gene under the LAT
promoter (one in each viral long repeat). We also generated a
rescued virus by co-transfection and homologous recombination of
DNA from the infectious HSV-CD80 with the original pLAT1.6
plasmid, as above. This rescued virus behaved similarly to that of
the dLAT2903 and WT HSV-1 strain McKrae suggesting that it is
the expression of CD80 by the HSV-CD80, rather than a defect in
the recombinant virus, which mediates the differences between
HSV-CD80 with that of dLAT2903 and wt McKrae with regards
to their effect on DCs. The kinetics of virus replication between
the rescued virus was similar to that of dLAT2903 virus, thus in all
experiments described here we used the well characterized
dLAT2903 virus also we call it parental virus instead of the
HSV-CD80 rescued virus that we made.
Southern analyses
Briefly, viral DNA was digested with BamHI; the restriction
fragments were separated in a 0.9% agarose gel, transferred to
Zeta paper, rinsed in 26 SSC (16 SSC is 0.15 M NaCl plus
0.015 M sodium citrate) for 5 min, and cross-linked to the
membrane by UV light; and DNA-DNA hybridization was
performed with
32P-labeled CD80 as previously described [22,62].
Virus replication in tissue culture
RS cell monolayers at 70–80% confluency were infected with
1 PFU/cell of parental virus or HSV-CD80. Virus was harvested
at various times post infection by subjecting the cell monolayers to
two freeze-thaw cycles. Virus titers were determined using
standard plaque assays on RS cells as described previously [63].
DCs culture in vitro
Bone marrow (BM) for the generation of mouse DCs was
isolated by flushing femurs and tibiae with PBS as we described
previously [10]. The cells were centrifuged and resuspended in
complete medium supplemented with murine GM-CSF (100 ng/
ml; Peprotech, NJ) to enhance replication of DCs [64]. The cells
were plated in non-tissue culture plastic Petri dishes (1 bone per
10 cm dish) for 5 days at 37uC with CO2. After 5 days, the media
was removed, the adherent cells were recovered by incubating the
cells for 5 min. at 37uC with Versene (Invitrogen, San Diego, CA).
Cells were washed, counted, and plated onto tissue-culture dishes
for use the following day.
Virus replication in DCs
Monolayers of BM-derived DCs were infected with 1 or
10 PFU/cell of HSV-1 strain McKrae, parental virus, or HSV-
CD80 for 1 hr at 37uC. Virus was then removed and the infected
cells were washed 3X and fresh media was added to each well.
The monolayers including media were harvested at various times
by freezing at 280uC. Virus was harvested by two cycles of freeze-
thawing and infectious virus titers were determined by standard
plaque assays on RS cells as we previously described [22,65].
Antibody blocking study
Previously we have shown that rat anti-mouse PD-L1 (clone
10F.2H11) antibody blocks interaction of PD-L1 with CD80 but
not PD-1 [19,66]. Monolayers of DCs were incubated with 50 ug/
ml of 10F.2H11 antibody, irrelevant antibody of the same isotype
(eBioscience), or no antibody. Each 16107 PFU/ml of HSV-
CD80 was similarly incubated with each antibody for 1 hr at
37oC. The mixture of virus-antibody was added to the mixture of
DCs-antibody at 0.1 or 1 PFU/cell for 1 hr at 37oC. Virus was
then removed and the infected cells were washed 3X and fresh
media containing the same concentration of each antibody was
added to each well. The monolayers including media were
harvested at various times by freezing at 280uC. Virus was
harvested by two cycles of freeze-thawing and infectious virus titers
were determined by standard plaque assay as above.
Isolation of T cells
Donor WT C57BL/6 mouse spleens were pooled, and single-
cell suspensions were prepared as described previously [67]. Total
T cells were isolated using magnetic beads as described by the
manufacturer (Miltenyi Biotec, San Diego, CA).
RNA extraction and cDNA preparation in vitro
DCs grown in 24-well plates were infected with 1 PFU/cell of
HSV-CD80 or parental virus. RNA preparation was done as we
previously described [68]. The RNA yield from all samples was
determined by spectroscopy (NanoDrop ND-1000, NanoDrop
Technologies, Inc., Wilmington, Delaware) and 1000 ng of total
RNA was reverse-transcribed using random hexamer primers and
Murine Leukemia Virus (MuLV) Reverse Transcriptase (Applied
Biosystems, Foster City, CA), in accordance with the manufac-
turer’s recommendations.
TaqMan Real-Time PCR
The expression levels of ICP0, TK, and CD80 genes, along with
the expression of the cellular IFN-c, and GAPDH (internal
control) genes were evaluated using commercially available
TaqMan Gene Expression Assays as we described previously
[22,68]. Primer-probe sets consisted of two unlabeled PCR
primers and the FAM
TM dye-labeled TaqMan MGB probe
formulated into a single mixture. The HSV-1 ICP0 and TK
primers and probe used were as follows: 1) ICP0: forward primer,
59- CGGACACGGAACTGTTCGA-39; reverse primer, 59-
CGCCCCCGCAACTG-39; and probe, 59-FAM-CCCCATC-
CACGCCCTG-39 – Amplicon length=111 bp; and 2) TK:
forward primer, 59- CAGTAGCGTGGGCATTTTCTG-39; re-
verse primer, 59-CCTCGCCGGCAACAAAA-39; and probe, 59-
FAM-CTCCAGGCGGACTTC-39 – Amplicon length=59 bp.
For the CD80 (Assay ID MM00711660_m1 - Amplicon
length=117 bp), IFN-c (ABI assay I.D. Mm00801778_m1 –
Amplicon length=101 bp); and GAPDH internal control (Assay
ID m999999.15_G1 - Amplicon length=107 bp) primers sets
from Applied Biosystems were used.
Quantitative real-time PCR was performed as we described
previously [68] in triplicate for each sample at each time point.
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of the GAPDH housekeeping gene (endogenous control).
Flow Cytometric Analysis
BM-derived DCs were infected with 1 PFU/cell of HSV-CD80
and parental virus or mock infected for 24 hr. Infected or mock-
infected cells were harvested and stained with anti-CD11c-
PacBlue, anti-CD80-PE, anti-PD-L1-APC, anti-HSV-1 gC-FITC,
anti-CD83-APC, and anti-CD69-PE from BD PharMingen (San
Diego, CA) and Biolegend (San Diego, CA) and then analyzed by
FACS as previously described [69].
Co-culture of infected DCs with T cells
DCs from WT mice were infected with 1 PFU/cell of HSV-
CD80, parental virus or mock infected. At 24 hr PI, 1610
6
infected or mock-infected DCs were co-cultured with 1610
6 T
cells from naive WT or CD28
-/- mice for 24 and 48 hr. The
monolayers were harvested and stained with anti-CD3-PercP-A
and anti-PD-1-PE antibodies for FACS analyses (BD PharMingen,
San Diego, CA).
Immunofluorescence
RS cell monolayers grown on Lab-Tex chamber slides were
infected with 1 or 10 PFU/cell of parental virus or recombinant
HSV-CD80 for 12 and 24 hr. Slides were then blocked for 30 min
at room temperature (RT) in PBS-T containing 1% w/v BSA
(PBS-TB). Slides were washed, incubated for 1 hr at RT with anti-
HSV-1 gC-FITC (Genway, #20-902-170310) antibody. In some
experiments DCs isolated from WT, PD-L1
-/-, and PD-L2
-/- mice
grown on Lab-Tex chamber slides were infected with 1 PFU/cell
of HSV-CD80 or parental virus for 24 hr. Cells were fixed by
incubating slides in methanol for 10 min followed by acetone for
5 min at -206C. Afterwards, slides were rinsed 36for 5 min each
at RT in PBS containing 0.05% v/v Tween-20 (PBS-T). Slides
were then blocked for 30 min at RT in PBS-T containing 1% w/v
BSA (PBS-TB). Slides were washed, incubated for 1 hr at RT with
anti-HSV-1 gC-FITC, anti-CD80, anti-PD-L1, anti-HVEM, and
anti-nectin-1 antibodies (Genway, eBioscience, San Diego, CA;
abcam, Cambridge, MA). Sections were washed 36with PBS, air
dried and mounted with Prolong Gold DAPI mounting medium
(Invitrogen). Images were captured at 206 on independent
fluorescence channels using a Nikon C1 eclipse inverted confocal
microscope.
Conclusion
Dendritic cells (DCs) play key roles in host defense against HSV-
1 infection. Although DCs can be infected by HSV-1, but DCs are
resistant to wild type HSV-1 replication. We report here that, in
contrast to wild type HSV-1, DCs were susceptible to infection by
a recombinant HSV-1 expressing murine CD80 (B7-1) under the
LAT promoter. The susceptibility of DCs to HSV-CD80 infection
was due to binding of viral expressed CD80 to PD-L1. Binding of
CD80 expressed by HSV-CD80 to PD-L1 reduced PD-L1
interaction with PD-1 on T cells leading to lower T cell exhaustion
and higher expression of IFN-c.
Supporting Information
Figure S1 CD83 and CD69 expression in BM-derived
DCs. Subconfluent monolayers of DCs isolated from WT
C57BL/6 mice were infected with 1 PFU/cell of HSV-CD80,
parental virus, or mock-infected. At 24 hr PI, cells were harvested
and reacted with anti-CD11c, anti-CD83 and anti-CD69
antibodies and FACS analysis was performed by gating the
CD11c
+ cells for expression of CD83 and CD69. Experiments
were repeated twice.
(PDF)
Figure S2 Co-culture of HSV-CD80 infected DCs with
naive CD28
-/- T cells. DCs from WT C57BL/6 mice were
infected with 1 PFU/cell of HSV-CD80, parental virus, or mock-
infected. At 48 hr PI, the infected DCs were incubated with T cells
isolated from naive C57BL/6-CD28
-/- mice at a 1:1 ratio. As a
control some T cells were incubated without DCs (not shown).
FACS analyses were carried out using anti-CD3 and anti-PD-1
antibodies. Graphs show the PD-1 staining intensity of CD3
+
gated T cells. Number indicates the percent of PD-1
+CD3
+
expressing T cells per treatment. The left peak represent the PD-1
negative T cells, while the right peak (R9) represent PD-1 positive
T cells. Experiments were repeated twice.
(PDF)
Figure S3 Detection of HSV-1 receptors on the surface
of DCs. Subconfluent monolayers of DCs isolated from WT
C57BL/6 mice were grown on Lab-Tek chamber slides and
probed with anti-CD11c/anti-HVEM or anti-CD11c/anti-nectin-
1 antibodies. Panels: A and B) Representative Photomicrographs
of stained DCs. DAPI is shown as a nuclear counter-stain; and C)
Quantification of photomicrographs. Different areas of 3 slides
were imaged and the numbers of CD11c
+, CD11c
+HVEM
+, and
CD11c
+nectin-1
+ cells were counted. Each point represents the
mean 6 SEM from 24 images.
(PDF)
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